Skip to content

Author

Ali Doostmohammadi

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

In-Silico Identification and Molecular Dynamics Characterization of FDA-Approved Drug Candidates Targeting MAO-B for Parkinson’s Disease Drug Repurposing

A knowledge-based virtual screening and drug-repurposing workflow was applied to identify FDA-approved small molecules predicted to bind favourably to MAO-B, highlighting apixaban and rimacalib as predicted MAO-B-binding candidates warranting biochemical and pharmacological validation to establish their repurposing pot...

Atefeh Hemmat, Ali Doostmohammadi · 0 citations
Review Aug 2026

Exosome-derived biomarkers as non-invasive tools in stroke, Parkinson’s disease, and Alzheimer’s disease

This review focuses on exosome-derived proteins and small non-coding RNAs as promising non-invasive biomarkers for stroke, PD, and AD, given the accessibility and stability of exosomes in biological fluids, and examines their potential diagnostic and therapeutic relevance.

Athar Talebi, Samira Nabili, Mobarakeh Alaei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.